Selected research
Industry Research
Pharma Excipients Industry Research Report 2026
Market perspective
The global Pharma Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharma Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharma Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharma Excipients include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharma Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma Excipients Market by Company
J.M. Huber Corporation
Evonik
Eastman Chemical Company
DOW Chemical Company
Cargill
BASF
Archer Daniels Midland (ADM)
AkzoNobel
ABITEC Corporation
Pharma Excipients Segment by Type
Alcohols
Polymers
Minerals
Sugar
Others
Pharma Excipients Segment by Application
Oral Solid Dosage Forms (OSDF)
Others
Pharma Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharma Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharma Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alcohols
- Polymers
- Minerals
- Sugar
- Others
Applications
- Oral Solid Dosage Forms (OSDF)
- Others
Companies covered
- J.M. Huber Corporation
- Evonik
- Eastman Chemical Company
- DOW Chemical Company
- Cargill
- BASF
- Archer Daniels Midland (ADM)
- AkzoNobel
- ABITEC Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharma Excipients Market Size (2021-2032)
- 2.2.2 Global Pharma Excipients Sales (2021-2032)
- 2.2.3 Global Pharma Excipients Market Average Price (2021-2032)
- 2.3 Pharma Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Alcohols
- 2.3.3 Polymers
- 2.3.4 Minerals
- 2.3.5 Sugar
- 2.3.6 Others
- 2.4 Pharma Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral Solid Dosage Forms (OSDF)
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharma Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharma Excipients Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Pharma Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharma Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharma Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharma Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharma Excipients, Product Type & Application
- 3.8 Global Manufacturers of Pharma Excipients, Established Date
- 3.9 Global Pharma Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 J.M. Huber Corporation
- 4.1.1 J.M. Huber Corporation Company Information
- 4.1.2 J.M. Huber Corporation Business Overview
- 4.1.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
- 4.1.5 J.M. Huber Corporation Recent Developments
- 4.2 Evonik
- 4.2.1 Evonik Company Information
- 4.2.2 Evonik Business Overview
- 4.2.3 Evonik Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Evonik Pharma Excipients Product Portfolio
- 4.2.5 Evonik Recent Developments
- 4.3 Eastman Chemical Company
- 4.3.1 Eastman Chemical Company Company Information
- 4.3.2 Eastman Chemical Company Business Overview
- 4.3.3 Eastman Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
- 4.3.5 Eastman Chemical Company Recent Developments
- 4.4 DOW Chemical Company
- 4.4.1 DOW Chemical Company Company Information
- 4.4.2 DOW Chemical Company Business Overview
- 4.4.3 DOW Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
- 4.4.5 DOW Chemical Company Recent Developments
- 4.5 Cargill
- 4.5.1 Cargill Company Information
- 4.5.2 Cargill Business Overview
- 4.5.3 Cargill Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cargill Pharma Excipients Product Portfolio
- 4.5.5 Cargill Recent Developments
- 4.6 BASF
- 4.6.1 BASF Company Information
- 4.6.2 BASF Business Overview
- 4.6.3 BASF Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BASF Pharma Excipients Product Portfolio
- 4.6.5 BASF Recent Developments
- 4.7 Archer Daniels Midland (ADM)
- 4.7.1 Archer Daniels Midland (ADM) Company Information
- 4.7.2 Archer Daniels Midland (ADM) Business Overview
- 4.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
- 4.7.5 Archer Daniels Midland (ADM) Recent Developments
- 4.8 AkzoNobel
- 4.8.1 AkzoNobel Company Information
- 4.8.2 AkzoNobel Business Overview
- 4.8.3 AkzoNobel Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AkzoNobel Pharma Excipients Product Portfolio
- 4.8.5 AkzoNobel Recent Developments
- 4.9 ABITEC Corporation
- 4.9.1 ABITEC Corporation Company Information
- 4.9.2 ABITEC Corporation Business Overview
- 4.9.3 ABITEC Corporation Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
- 4.9.5 ABITEC Corporation Recent Developments
5 Global Pharma Excipients Market Scenario by Region
- 5.1 Global Pharma Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharma Excipients Sales by Region: 2021-2032
- 5.2.1 Global Pharma Excipients Sales by Region: 2021-2026
- 5.2.2 Global Pharma Excipients Sales by Region: 2027-2032
- 5.3 Global Pharma Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Pharma Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Pharma Excipients Revenue by Region: 2027-2032
- 5.4 North America Pharma Excipients Market Facts & Figures by Country
- 5.4.1 North America Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharma Excipients Sales by Country (2021-2032)
- 5.4.3 North America Pharma Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharma Excipients Market Facts & Figures by Country
- 5.5.1 Europe Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharma Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Pharma Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Pharma Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharma Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharma Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharma Excipients Market Facts & Figures by Country
- 5.7.1 South America Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharma Excipients Sales by Country (2021-2032)
- 5.7.3 South America Pharma Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pharma Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharma Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharma Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharma Excipients Sales by Type (2021-2032)
- 6.1.1 Global Pharma Excipients Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Pharma Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Pharma Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Pharma Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharma Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharma Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharma Excipients Sales by Application (2021-2032)
- 7.1.1 Global Pharma Excipients Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Pharma Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Pharma Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Pharma Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharma Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharma Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharma Excipients Value Chain Analysis
- 8.1.1 Pharma Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharma Excipients Production Mode & Process
- 8.2 Pharma Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharma Excipients Distributors
- 8.2.3 Pharma Excipients Customers
9 Global Pharma Excipients Analyzing Market Dynamics
- 9.1 Pharma Excipients Industry Trends
- 9.2 Pharma Excipients Industry Drivers
- 9.3 Pharma Excipients Industry Opportunities and Challenges
- 9.4 Pharma Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst